AntibioticDB

SCH79797

Protease-activated receptor 1 (PAR1) antagonist

University of California, San Diego School of Medicine. Department of Molecular Medicine, The Scripps Research Institute.

2018

Highest development stage: Preclinical
Development status: Active
Gram-negative activity
Mechanism of Action/Target pathogen: Antibiotic effect with disruption of the E. coli cell membrane.
GtoPDB link: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10971
Source: https://academic.oup.com/jac/article/73/6/1586/4921301?searchresult=1
Compound/Drug Structure: https://pubchem.ncbi.nlm.nih.gov/compound/4259181